Announcements Trials
Browse Landscape

Status

Completed 1Active not recruiting 1

Sponsor Class

NETWORK 1

Study Type

Observational 1

Sponsor

Cancer Type

Gynecologic 2CNS 2Thoracic 1Sarcoma 1Other neoplasm 1Head & Neck 1Genitourinary 1Endocrine 1Breast 1

Conditions

Wilms Tumor 1Kidney Neoplasms 1

Interventions

Docetaxel 205Prednisone 151enzalutamide 128Gemcitabine 122Radiotherapy 116Sunitinib 112Cisplatin 102Leuprolide 98pembrolizumab 95Abiraterone Acetate 94bicalutamide 87Nivolumab 85Goserelin 83Sorafenib 80Paclitaxel 79Carboplatin 77Everolimus 72Bevacizumab 71Magnetic Resonance Spectroscopy 65acetyl-2-naphthylalanyl-3-chlorophenylalanyl-1-oxohexadecyl-seryl-4-aminophenylalanyl(hydroorotyl)-4-aminophenylalanyl(carbamoyl)-leucyl-ILys-prolyl-alaninamide 61pazopanib 56radium Ra 223 dichloride 50Ipilimumab 49Zoledronic Acid 47Radiosurgery 43Cyclophosphamide 43Filgrastim 42abiraterone 41gallium 68 PSMA-11 40Surveys and Questionnaires 40

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Completed × Spectrum Analysis × Genitourinary × Clear all
NCT01542333 2016-05-18

Studying Biomarkers in Samples From Younger Patients With Wilms Tumor

Children's Oncology Group

Completed
20 enrolled
Genitourinary

Kidney Neoplasms, Wilms Tumor

Data powered by HemOnc (CC BY 4.0) Colophon âš¡